Literature DB >> 3994505

The median lethal dose and its estimation.

D J Finney.   

Abstract

An important paper by Zbinden and Fluri-Roversi (1981) has shown the many weaknesses in any policy or regulatory system that regards an estimated LD50 in an animal species as an adequate guide to toxicity in man. The present paper draws attention to some statistical aspects of LD50 estimation that are too often neglected or misunderstood when this quantity is wanted. It is solely concerned with practice when a LD50 must be estimated, and deliberately does not approach the broader issues of whether the LD50 should be estimated. A first need is clear distinction between the true but unknown form of dependence of mortality on dose and the estimate of it (or of a particular property such as the LD50) that is obtainable from an experiment. Some assumptions are necessary before any estimation is possible. The graphical and semi-graphical methods that once were popular because of their simplicity and speed are today only reasonable as a last resort, when data are wholly inadequate and all that can be found is a very rough preliminary indication. Many "simple" arithmetical methods have been shown to be inherently bad, in that equally simple alternatives are usually more precise and less subject to bias. The Spearman-Kärber method remains as a useful possibility, demanding little knowledge of the form of the response curves but often needing other unverifiable assumptions. For most purposes, maximum likelihood estimation of a parametric formulation of the response curve is the best choice, not only because of theoretical merits but also because it can now be performed on a microcomputer in a very few seconds.

Entities:  

Mesh:

Year:  1985        PMID: 3994505     DOI: 10.1007/bf00295156

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  6 in total

1.  USE OF MOVING AVERAGES AND INTERPOLATION TO ESTIMATE MEDIAN-EFFECTIVE DOSE: I. Fundamental Formulas, Estimation of Error, and Relation to Other Methods.

Authors:  W R Thompson
Journal:  Bacteriol Rev       Date:  1947-06

2.  A simplified method of evaluating dose-effect experiments.

Authors:  J T LITCHFIELD; F WILCOXON
Journal:  J Pharmacol Exp Ther       Date:  1949-06       Impact factor: 4.030

3.  The curve doses vs survival time in the evaluation of acute toxicity.

Authors:  L Molinengo
Journal:  J Pharm Pharmacol       Date:  1979-05       Impact factor: 3.765

4.  The LD50 test: some considerations of precision.

Authors:  D O Chanter; R Heywood
Journal:  Toxicol Lett       Date:  1982-02       Impact factor: 4.372

5.  Significance of the LD50-test for the toxicological evaluation of chemical substances.

Authors:  G Zbinden; M Flury-Roversi
Journal:  Arch Toxicol       Date:  1981-04       Impact factor: 5.153

6.  Acute toxicity of oral diquat (1,1'-ethylene-2,2'-bipyridinium) in cynomolgus monkeys.

Authors:  L M Cobb; P Grimshaw
Journal:  Toxicol Appl Pharmacol       Date:  1979-11       Impact factor: 4.219

  6 in total
  13 in total

1.  Deciphering the biodiversity of Listeria monocytogenes lineage III strains by polyphasic approaches.

Authors:  Hanxin Zhao; Jianshun Chen; Chun Fang; Ye Xia; Changyong Cheng; Lingli Jiang; Weihuan Fang
Journal:  J Microbiol       Date:  2011-11-09       Impact factor: 3.422

Review 2.  Invited contribution: acute toxicity testing, public responsibility and scientific challenges.

Authors:  G Zbinden
Journal:  Cell Biol Toxicol       Date:  1986-09       Impact factor: 6.691

3.  Divergence of noise vulnerability in cochleae of young CBA/J and CBA/CaJ mice.

Authors:  Kevin K Ohlemiller; Mary E Rybak Rice; Erin A Rellinger; Amanda J Ortmann
Journal:  Hear Res       Date:  2010-11-23       Impact factor: 3.208

4.  The time of administration of 3'-azido-3'-deoxythymidine (AZT) determines its host toxicity with possible relevance to AZT chemotherapy.

Authors:  R Zhang; Z Lu; C R Diasio; T Liu; S J Soong
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

5.  Biological Safety of a Highly Purified 10% Liquid Intravenous Immunoglobulin Preparation from Human Plasma.

Authors:  Caroline Goussen; Steve Simoneau; Soline Bérend; Christine Jehan-Kimmel; Anne Bellon; Céline Ducloux; Bruno You; Philippe Paolantonacci; Monique Ollivier; Ludovic Burlot; Sami Chtourou; Benoît Flan
Journal:  BioDrugs       Date:  2017-06       Impact factor: 5.807

6.  Characteristics and Lethality of a Novel Recombinant  Dermonecrotic Venom Phospholipase D from  Hemiscorpius lepturus.

Authors:  Elham Torabi; Mahdi Behdani; Mohammad Hosseininejad Chafi; Reza Moazzami; Jean-Marc Sabatier; Vahid Khalaj; Delavar Shahbazzadeh; Kamran Pooshang Bagheri
Journal:  Toxins (Basel)       Date:  2017-03-13       Impact factor: 4.546

7.  Toxicity and Potential Pharmacological Activities in the Persian Gulf Venomous Sea Anemone, Stichodactyla haddoni.

Authors:  Ziba Moghadasi; Shahla Jamili; Delavar Shahbazadeh; Kamran Pooshang Bagheri
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

8.  Molluscicidal effectiveness of Luo-Wei, a novel plant-derived molluscicide, against Oncomelania hupensis, Biomphalaria alexandrina and Bulinus truncatus.

Authors:  Tie-Wu Jia; Wei Wang; Le-Ping Sun; Shan Lv; Kun Yang; Neng-Min Zhang; Xi-Bao Huang; Jian-Bing Liu; Han-Cheng Liu; Rui-Hua Liu; Fathia A Gawish; Mohamed R Habib; Mohamed A El-Emam; Charles H King; Xiao-Nong Zhou
Journal:  Infect Dis Poverty       Date:  2019-03-31       Impact factor: 4.520

9.  Safety evaluation of Bon-santé cleanser® polyherbal in male Wistar rats.

Authors:  O E Kale; O Awodele
Journal:  BMC Complement Altern Med       Date:  2016-07-07       Impact factor: 3.659

10.  Cellular cholesterol is required for porcine nidovirus infection.

Authors:  Ji Hyun Jeon; Changhee Lee
Journal:  Arch Virol       Date:  2017-09-07       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.